OHSU
Return to Listing

3 result(s) for Lung Cancers

PI Name Protocol # Title
Ariel Lopez-Chavez IRB00007252 Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics with Non-Small Cell Lung Cancer
Alan Sandler IRB00007669 An Open Label, Multi-center, IRESSA Clinical Access Program of Gefitinib 250 mg (IRESSA) for the Continued Treatment of Patients in the United States Who Are Currently Benefiting or Have Benefited from Gefitinib Treatment
Alan Sandler IRB00009059 National Lung Cancer Partnership- Lung Cancer Mutation Consortium
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program